Protara Therapeutics
TARA
TARA
113 hedge funds and large institutions have $237M invested in Protara Therapeutics in 2026 Q1 according to their latest regulatory filings, with 30 funds opening new positions, 48 increasing their positions, 23 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
8% more funds holding
Funds holding: 105 → 113 (+8)
7.1% more ownership
Funds ownership: 77.14% → 84.24% (+7.1%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Holders
113
Holding in Top 10
2
Calls
$1.31M
Puts
$245K
Top Buyers
| 1 | +$12.3M | |
| 2 | +$9.6M | |
| 3 | +$6.66M | |
| 4 |
PSC
Patient Square Capital
Menlo Park,
California
|
+$6.1M |
| 5 |
BlackRock
New York
|
+$5.84M |
Top Sellers
| 1 | -$6.71M | |
| 2 | -$5.56M | |
| 3 | -$5.13M | |
| 4 |
MS
Maven Securities
St Helier,
Jersey
|
-$4.02M |
| 5 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$3.46M |
